What is the price-to-earnings ratio of Zoetis?
The price-earnings ratio of Zoetis is currently 8.52.
Zoetis P/S 2024
Zoetis P/S
8.52
Ticker
ZTS
ISIN
US98978V1035
WKN
A1KBYX
As of Dec 3, 2024, Zoetis's P/S ratio stood at 8.52, a -5.12% change from the 8.98 P/S ratio recorded in the previous year.
The Zoetis P/S history
Zoetis Aktienanalyse
What does Zoetis do?
Zoetis Inc. is a leading company in the development and marketing of animal health technology and solutions. The company specializes in innovative products for animals such as dairy cattle, pigs, poultry, dogs, cats, and horses. Zoetis was founded in 1952 as a subsidiary of Pfizer and operated as Pfizer Animal Health. In 2013, the company was finally spun off from Pfizer and became Zoetis Inc. Zoetis focuses on the development, manufacturing, and marketing of products for livestock and pets, including vaccines, pharmaceuticals, biological therapies, and diagnostics. The company operates globally and has its headquarters in Parsippany, New Jersey. Zoetis' business model consists of various business segments divided into animal categories: cattle, pigs, poultry, pets, and horses. Each of these business segments offers specialized solutions for animal owners and veterinarians. In the cattle products segment, Zoetis offers products for dairy cows, beef cattle, and calves. They also provide a variety of prevention and treatment solutions for major animal health issues such as mastitis, reproductive disorders, and respiratory problems. In the swine segment, Zoetis offers prevention and treatment solutions for infectious diseases and parasite control. They also provide products for promoting swine health and weight gain. In the poultry segment, Zoetis offers solutions for the prevention and treatment of infectious diseases. The company's products aim to improve animal health, productivity, and efficiency. Zoetis also offers products for the pet segment, including vaccines, pharmaceuticals, and therapies for dogs, cats, and other pets. Here, the company also provides solutions for major health issues such as heart diseases, pain management, and parasite control. In the horse segment, Zoetis offers solutions for the prevention and treatment of diseases such as equine rhinopneumonia, worm infestations, and arthritis. They also provide products for promoting horse health and performance. Zoetis is known for a variety of innovative products used by animal owners and veterinarians worldwide. One example is ScourGuard® 4KC, a vaccine that protects calves from diarrheal diseases caused by common bacteria. This vaccine has already proven to be highly effective in controlling bowel diseases in calves. Zoetis has also developed and marketed the first FDA-approved product for pain management in dogs (Rimadyl®), as well as the first licensed product for the treatment of giardia in dogs (Panacur®). In summary, Zoetis, as a global leader in the animal health industry, puts innovation and quality at the forefront. With a wide range of products and solutions in various animal categories, Zoetis is a key player in the animal health industry. Zoetis ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Zoetis's P/S Ratio
Zoetis's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Zoetis's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Zoetis's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Zoetis’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Zoetis stock
How has the price-earnings ratio of Zoetis changed compared to last year?
The price-to-earnings ratio of Zoetis has increased by -5.12% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Zoetis high compared to other companies?
Yes, the price-to-earnings ratio of Zoetis is high compared to other companies.
How does an increase in the price-earnings ratio of Zoetis affect the company?
An increase in the price-earnings ratio of Zoetis would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Zoetis affect the company?
A decrease in the price-earnings ratio of Zoetis would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Zoetis?
Some factors that influence the price-earnings ratio of Zoetis are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Zoetis pay?
Over the past 12 months, Zoetis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zoetis is expected to pay a dividend of 2.03 USD.
What is the dividend yield of Zoetis?
The current dividend yield of Zoetis is .
When does Zoetis pay dividends?
Zoetis pays a quarterly dividend. This is distributed in the months of February, May, August, November.
How secure is the dividend of Zoetis?
Zoetis paid dividends every year for the past 18 years.
What is the dividend of Zoetis?
For the upcoming 12 months, dividends amounting to 2.03 USD are expected. This corresponds to a dividend yield of 1.15 %.
In which sector is Zoetis located?
Zoetis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zoetis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zoetis from 12/3/2024 amounting to 0.432 USD, you needed to have the stock in your portfolio before the ex-date on 10/31/2024.
When did Zoetis pay the last dividend?
The last dividend was paid out on 12/3/2024.
What was the dividend of Zoetis in the year 2023?
In the year 2023, Zoetis distributed 1.3 USD as dividends.
In which currency does Zoetis pay out the dividend?
The dividends of Zoetis are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Zoetis stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank
Andere Kennzahlen von Zoetis
Our stock analysis for Zoetis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zoetis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
